Research and Markets: 2013 Report on the In-Vitro Diagnostic Substance Manufacturing Industry Features Players such as Hologic, Inc. and Quidel Corporation

Research and Markets (http://www.researchandmarkets.com/research/2t6sj7/invitro) has announced the addition of Supplier Relations US, LLC's new report "In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [2013 Q4 Edition]" to their offering.

The industry's revenue for the year 2012 was reported at $12.6 billion USD, with an estimated gross profit of 43.66%. The industry used a projected 64 percent of its full production capacity in 2012. The industry could have increased its total shipment value to $19.6 billion USD under full production capacity. This industry did not have direct foreign trade statistics. The report nevertheless depicted relevant foreign trade data from a higher level NAICS industry or industry group.

This 2013 year-end publication of In-Vitro Diagnostic Substance Manufacturing Industry report is the comprehensive market research guide for the industry. It contains the latest information on the industry's key financial data, competitive landscape, cost and pricing, and trends during the current environment, including the output and shipment changes over the past months.

At 173 pages with over 150 charts and tables, the report covers topics such as current macroeconomic trends, granular product data, global trade, channel mix, government demand, and labor structure. It uses over a decade of historical data to forecast industry trends through 2017 on the domestic market, global market and overseas growth opportunities. This current report contains shipment data, inventory levels, international trade volume, and industry specific price indices available through September 2013. Industry analysts and Fortune 500 customers rely on this quarterly report to make accurate forecasts and planning in today's uncertain economy.

Companies Mentioned:

- Abaxis Inc.

- Affymetrix, Inc.

- Alere

- Amag Pharmaceuticals Inc.

- ARCA biopharma

- Bracco Diagnostic Inc.

- Celsis In Vitro Technologies

- EXACT Sciences Corporation

- General Electric Company

- Hologic, Inc.

- IDEXX Laboratories, Inc.

- Johnson & Johnson

- Monogram Biosciences, Inc.

- Myriad Genetics, Inc.

- OraSure Technologies, Inc.

- Peregrine Pharmaceuticals, Inc.

- Quidel Corporation

- Radient Pharmaceuticals Corporation

For more information visit http://www.researchandmarkets.com/research/2t6sj7/invitro

Source: Supplier Relations US, LLC

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
[e-mail]
U.S. Fax: [phone]
Fax (outside U.S.): [phone]
Sector: In Vitro Diagnostics